Home | About Jay Hochman -Pediatric Gastroenterology Blog | Archives
October 28, 2015 7:00 am
I started thinking about this question after a recent study (DS Vitale, et al. JPGN 2015; 61: 408-10) examined adherence at a single pediatric center (2010-2012). Adherence indicated “those who attended >80% of scheduled infusions.” Key findings:
My take: One of the key advantages of infusion therapy is improved and documented adherence. Infusions also provide opportunities to assess patient in a scheduled manner. This study shows that subsets of patients with scheduled infusions have suboptimal adherence — another target for quality improvement!
Posted by gutsandgrowth
Categories: Pediatric Gastroenterology Intestinal Disorder
Tags: adherence, Crohn's disease, infliximab
Mobile Site | Full Site
Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.
[…] What is Your Infliximab Adherence Rate? | gutsandgrowth […]
By Gold Medal Winner: Infliximab (anti-TNF competition) | gutsandgrowth on August 15, 2016 at 7:01 am
[…] What is Your Infliximab Adherence Rate? | gutsandgrowth […]
By February Briefs | gutsandgrowth on February 28, 2017 at 7:00 am